San Francisco, CA2 Active Studies

Diabetic Retinopathy Clinical Trials in San Francisco, CA

Find 2 actively recruiting diabetic retinopathy clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
860
Enrolling

Recruiting Diabetic Retinopathy Studies in San Francisco

About Diabetic Retinopathy Clinical Trials in San Francisco

Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.

There are currently 2 diabetic retinopathy clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 860 participants. Research is being sponsored by Jaeb Center for Health Research, Boehringer Ingelheim. Clinical trial participation is free and participants receive study-related medical care at no cost.

Diabetic Retinopathy Clinical Trials in San Francisco — FAQ

Are there diabetic retinopathy clinical trials in San Francisco?

Yes, there are 2 diabetic retinopathy clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What diabetic retinopathy treatments are being tested?

The 2 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.

Data updated March 2, 2026 from ClinicalTrials.gov